DR. JEFFREY KENT GIGUERE, MD

Plain English
This study looked at how older adults with advanced cancer are referred to rehabilitation services and how those referrals affect their daily functioning and survival. Researchers found that factors like impaired cognition and higher disability scores made doctors more likely to refer patients for rehabilitation, while having multiple medications decreased the chances of a referral. However, being referred did not significantly improve patients' daily activities or survival rates. Who this helps: This research benefits doctors and healthcare providers in understanding the factors influencing rehabilitation referrals for older cancer patients.

Plain English
This study looked at the effectiveness of the Generalized Anxiety Disorder Scale (GAD-7) for measuring anxiety in older adults with advanced cancer. Researchers found that the GAD-7 is a strong tool for identifying anxiety, with a high reliability score of 0.89, while the simpler GAD-2 scale also performed well, making it a potentially easier option to use. This is important because using accurate and efficient anxiety screening tools can help better support older cancer patients' mental health needs. Who this helps: This benefits older cancer patients by providing better anxiety assessment options.

Plain English
This study looked at how common it is for older cancer patients to change their treatment plans after the first round of palliative care, and what factors might lead to those changes. Out of 369 patients, 35% had their treatments modified, with older age, receiving more than one type of chemotherapy, having functional impairments, and lower income all increasing the likelihood of these modifications. This is important because it highlights the need for tailored treatment plans that consider the unique circumstances of older adults with cancer. Who this helps: This helps older cancer patients and their doctors by providing insights into how to better manage treatment options.

Plain English
This study looked at how exercise impacts symptoms of nerve damage (called chemotherapy-induced peripheral neuropathy or CIPN) in cancer patients undergoing specific types of chemotherapy. Researchers found that exercise reduced symptoms like cold sensitivity and numbness in hands and feet; on average, patients reported a decrease of 0.46 in cold sensitivity and 0.42 in numbness after a six-week exercise program. These findings are important as they suggest that exercise can help alleviate painful side effects of chemotherapy, improving the quality of life for patients. Who this helps: This benefits cancer patients receiving taxane, platinum, or vinca alkaloid-based chemotherapy.

Plain English
This study focused on women with breast cancer who were given coenzyme Q10 (CoQ10) and Vitamin E or a placebo to see how well they followed the treatment and how it affected their biomarker levels. The researchers found that while there was a moderate relationship between the levels of the vitamins in the blood, the connection between how well participants thought they followed the treatment and their actual biomarker levels was weak, showing that some who reported taking the supplements regularly did not see an increase in those levels. This matters because it suggests that self-reported information about taking medication can be misleading, highlighting the need for better ways to accurately measure adherence in clinical trials. Who this helps: This helps patients and doctors by improving the accuracy of treatment assessments in clinical research.

Plain English
This study looked at the quality of life of brain tumor survivors who received radiation therapy and were treated with either a drug called donepezil or a placebo for cognitive issues. Out of 198 patients, those with more severe cognitive symptoms at the start of the study experienced benefits in emotional well-being and social health after 12 weeks of donepezil treatment. However, those with fewer cognitive symptoms reported worse overall functioning and more fatigue from the treatment. Who this helps: This benefits brain tumor survivors dealing with cognitive issues after radiation therapy.

Plain English
This study looked at whether adding a drug called cetuximab to chemotherapy and radiation could help patients with esophageal cancer live longer. Researchers followed 328 patients and found that adding cetuximab did not improve overall survival rates after two years (45% with cetuximab vs. 44% without), and only 56% of patients who received cetuximab had a complete clinical response compared to 58% in the control group. These findings are important because they suggest that cetuximab may not be effective for all patients with esophageal cancer, highlighting the need for better-targeted treatments. Who this helps: This helps doctors and researchers seeking effective treatments for esophageal cancer patients.

Plain English
This study looked at how a specific yoga program called YOCAS® affects memory problems in cancer survivors. It found that participants who practiced YOCAS® reported a significant drop in memory difficulty, with an average improvement of 0.60 compared to just 0.16 for those who received standard care. This is important because memory issues can greatly impact the quality of life for cancer survivors, and effective interventions like yoga can help improve their everyday functioning. Who this helps: Cancer survivors experiencing memory difficulties.

Plain English
This study looked at how a 4-week yoga program called YOCAS helps older cancer survivors manage fatigue and other side effects after treatment. The research involved 97 survivors aged 60 and older, and those who took part in the yoga program reported significantly less overall fatigue and a lower burden from side effects compared to those who did not do yoga. This matters because it shows that yoga can improve the quality of life for older survivors by helping them feel less tired and better manage their health after cancer treatment. Who this helps: Older cancer survivors.

Plain English
This study looked at whether taking coenzyme Q10 (CoQ10) could help reduce fatigue and improve the quality of life for women who were newly diagnosed with breast cancer and about to start chemotherapy. Involving 236 women, the study found that taking 300 mg of CoQ10 daily for 24 weeks did not significantly change their reported levels of fatigue or quality of life compared to those taking a placebo. This matters because it suggests that CoQ10 may not be an effective way to alleviate treatment-related fatigue in these patients. Who this helps: This helps patients with breast cancer who are seeking ways to cope with fatigue during treatment.

Plain English
This study looked at different versions of a hormone called glucagon-like peptide-1 (GLP-1) to see which ones might be better at treating diabetes. Researchers found that certain modified versions, like [D-Ala(2)]GLP-1, showed a strong ability to lower blood sugar levels in mice that were both normal and diabetic, even though they didn’t always bind to receptors as effectively. This matters because developing stable and more effective GLP-1 treatments could lead to better diabetes management with fewer injections. Who this helps: Patients with diabetes.

Plain English
The study looked at how Hodgkin's disease spreads in the chest by using CT scans of 108 newly diagnosed patients. Researchers found that 77 of these patients showed signs of the disease spreading in a specific pattern, starting from the front of the chest and moving to nearby lymph nodes, and then potentially into the lungs. This understanding helps pinpoint Hodgkin's disease more accurately when symptoms overlap with other conditions, which can improve diagnosis and treatment decisions. Who this helps: This benefits doctors and patients by leading to more accurate diagnoses.